rf-fullcolor.png

 

September 6, 2013
by RAPS

Russia Decides Pre-2013 Device Clinical Trials Can Support Marketing Approval

Russia's Federal Service on Healthcare Surveillance (Roszdravnadzor) and the Ministry of Health have agreed that clinical trials conducted on medical devices prior to January 2013 can be used to support applications for the renewal of or new marketing registration for devices in the 2013-2014 timeframe. 

This comes as part of the agency's ongoing initiative to simplify the device registration procedure following consultations with industry in which concern was expressed about the existing re-registration process.

Commenting on the agency's decision, acting Roszdravnadzor head MichaelMurashko noted, "The theme of simplifying registration procedures is highly relevant today … with two main goals: to ensure the marketing of medical products with proven efficacy and safety, and to harmonize Russian legislation with that of developed countries."


Roszdravnadzor Notice

Read all Breaking News from RegLink

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.